![]() |
市场调查报告书
商品编码
1700082
2032 年螯合硒市场预测:按螯合剂、形态、等级、应用和地区分類的全球分析Chelated Selenium Market Forecasts to 2032 - Global Analysis By Chelating Agent (Glycine, Methionine and Other Chelating Agents), Form (Powder, Liquid and Granules), Grade, Application and By Geography |
根据 Stratistics MRC 的数据,全球螯合硒市场预计在 2025 年达到 8.6 亿美元,到 2032 年将达到 14.1 亿美元,预测期内的复合年增长率为 7.3%。
螯合硒是硒的一种形式,它与有机分子(如氨基酸或胜肽)结合,以增加生物有效性和吸收率。它广泛用于农业、膳食补充剂和动物营养,以促进抗氧化活性、免疫系统功能和整体健康。与无机硒源相比,螯合物增加了硒的稳定性和可用性,使其更有效地被人体利用。
根据国际饲料工业联合会(IFIF)的数据,全球每年生产超过10亿吨复合饲料。
动物营养需求不断成长
动物营养中对螯合硒的需求不断增加,因为它在提高牲畜健康和生产力方面发挥着重要作用。硒是一种重要的微量营养素,可以改善牲畜的免疫功能、生育能力和生长率,这与人们对高品质肉类和乳製品的日益关注相吻合。此外,严格的法规要求在饲料中补充硒以防止缺乏,这进一步推动了硒的采用。集约化农业的兴起和消费者对符合道德标准的畜产品的需求也促进了市场的成长。
严格遵守法规
FDA 和 EFSA 等机构强制限制硒的含量以防止过量摄取,製造商必须经过复杂的核准程序。遵守当地标准会增加生产成本并延迟产品发布,尤其是对于较小的营运商。此外,频繁更新的安全指南需要不断地进行再製造,这给业务带来了挑战。这些因素共同限制了市场可及性和增加了进入壁垒,从而抑制了市场成长。
人类营养补充品的扩展
硒具有公认的抗氧化作用,可以对抗氧化压力并支持甲状腺和免疫功能。慢性病的增加和人口老化正在推动对硒强化产品的需求。此外,个人化营养和洁净标示补充剂的趋势正在推动甲硫胺酸等配方的创新。向新兴市场的扩张,加上健康意识的增强,使人类营养成为市场参与者的有利可图的成长途径。
潜在的毒性问题
儘管过量摄取会带来毒性风险,包括硒中毒,这会损害器官和神经系统。这些担忧导致监管审查加大,消费者怀疑情绪加剧,尤其是在不受监管的市场。过度添加牲畜或人类产品可能导致召回、法律责任和声誉损害。此外,原物料采购品管不一致加剧了安全风险。这些因素威胁市场稳定,需要严格的品质保证和消费者教育来减轻负面影响。
新冠疫情扰乱了全球供应链,导致螯合硒市场原料短缺、生产延迟。停工减少了畜牧业的需求,经济的不确定性减缓了研发投资。相反,健康意识的提高刺激了对增强免疫力的补充剂的需求,部分抵消了损失。农业和营养保健品的疫情后復苏,加上供应链的稳定,正在推动市场逐步復苏。
预计甘氨酸市场在预测期内将占据最大份额
预计甘氨酸将在预测期内占据最大的市场占有率,因为其优异的生物利用度和稳定性使其成为动物饲料和药品的理想选择。它的成本效益和与各种配方的兼容性增强了其在畜牧业和水产养殖业的应用。此外,甘胺酸在降低植物氧化压力方面的作用扩大了其在农业应用中的用途。由于其成熟的供应链和在预防硒缺乏方面已证实的有效性,该领域巩固了其主导地位,特别是在集约农业地区。
预计在预测期内,液体部分将以最高的复合年增长率成长。
由于液体易于融入饲料混合物、肥料和营养补充剂中,预计预测期内液体部分将出现最高的成长率。液体螯合硒具有精确剂量和快速吸收的特点,对现代农业和精密农业具有吸引力。家禽和乳製品产业对液体补充剂的需求不断增加,加上封装技术的进步,将进一步推动成长。此外,水耕和叶面喷布在园艺中的广泛应用将推动其应用,预计这一领域将出现强劲增长。
在预测期内,由于严格的动物营养法规、先进的农业实践以及消费者对膳食补充剂的高度认识,预计北美将占据最大的市场占有率。该地区畜牧业发达,非常注重肉类质量,这导致对富硒饲料的需求增加。此外,强大的研发能力以及阿彻丹尼尔斯米德兰和嘉吉等主要企业的存在增强了市场主导地位。政府推动食品和饲料微量营养素强化的措施进一步加强了北美的主导地位。
由于畜牧业产量扩大、肉类消费量增加以及健康意识增强,预计亚太地区在预测期内的复合年增长率最高。中国和印度等国家正在投资现代农业技术和营养补充剂来解决硒缺乏问题。政府支持农业生产力的政策和都市化对加工食品的需求进一步刺激了人们的采用。此外,低生产成本和新兴经济体尚未开发的潜力使该地区成为吸引全球对螯合硒应用投资的高成长市场。
According to Stratistics MRC, the Global Chelated Selenium Market is accounted for $0.86 billion in 2025 and is expected to reach $1.41 billion by 2032 growing at a CAGR of 7.3% during the forecast period. Chelated selenium is a form of selenium bound to organic molecules, such as amino acids or peptides, to enhance bioavailability and absorption. It is extensively utilized in agriculture, nutritional supplements, and animal nutrition to promote antioxidant activity, immune system function, and general health. Compared to inorganic selenium sources, chelation increases the stability and efficacy of selenium, allowing the body to use it more effectively.
According to the International Feed Industry Federation (IFIF), over 1 billion tons of compound animal feed are produced annually worldwide.
Rising demand in animal nutrition
The increasing demand for chelated selenium in animal nutrition is driven by its critical role in enhancing livestock health and productivity. As a vital micronutrient, selenium improves immune function, fertility, and growth rates in animals, aligning with the growing focus on high-quality meat and dairy products. Additionally, stringent regulations mandating selenium supplementation in animal feed to prevent deficiencies further propel adoption. The rise in intensive farming practices and consumer demand for ethically sourced animal products also contribute to market growth.
Stringent regulatory compliance
Agencies like the FDA and EFSA enforce limits on selenium concentrations to prevent overexposure, requiring manufacturers to navigate complex approval processes. Compliance with regional standards increases production costs and delays product launches, particularly for small-scale players. Moreover, frequent updates to safety guidelines necessitate continuous reformulation, creating operational challenges. These factors collectively restrain market growth by limiting accessibility and increasing barriers to entry.
Expansion in human nutritional supplements
Recognized for its antioxidant properties, selenium combats oxidative stress and supports thyroid and immune functions. Rising prevalence of chronic diseases and aging populations amplify demand for selenium-enriched products. Furthermore, the trend toward personalized nutrition and clean-label supplements drives innovation in formulations like selenomethionine. Expansion into emerging markets, coupled with increasing health awareness, positions human nutrition as a lucrative growth avenue for market players.
Potential toxicity issues
Despite its benefits, excessive selenium intake poses toxicity risks, including selenosis, which can damage organs and nervous systems. Such concerns heighten regulatory scrutiny and consumer skepticism, particularly in unregulated markets. Incidents of over-supplementation in livestock or human products could lead to recalls, legal liabilities, and reputational damage. Additionally, inconsistent quality control in raw material sourcing exacerbates safety risks. These factors threaten market stability, necessitating rigorous quality assurance and consumer education to mitigate adverse impacts.
The Covid-19 pandemic disrupted global supply chains causing raw material shortages and production delays in the chelated selenium market. Lockdowns reduced demand from the livestock sector due to operational halts, while economic uncertainties slowed R&D investments. Conversely, heightened health awareness boosted demand for immune-boosting supplements, partially offsetting losses. Post-pandemic recovery in agriculture and nutraceuticals, coupled with stabilized supply chains, has driven gradual market resurgence.
The glycine segment is expected to be the largest during the forecast period
The glycine segment is expected to account for the largest market share during the forecast period due to its superior bioavailability and stability, making it ideal for animal feed and pharmaceuticals. Its cost-effectiveness and compatibility with diverse formulations enhance adoption in livestock and aquaculture industries. Additionally, glycine's role in reducing oxidative stress in plants amplifies its use in agricultural applications. The segment's established supply chain and proven efficacy in preventing selenium deficiencies solidify its leading position, particularly in regions with intensive farming practices.
The liquid segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid segment is predicted to witness the highest growth rate attributed to its ease of integration in feed mixes, fertilizers, and nutraceuticals. Liquid chelated selenium offers precise dosing and faster absorption, appealing to modern farming and precision agriculture. Rising demand for liquid supplements in poultry and dairy industries, coupled with advancements in encapsulation technologies, further drives growth. Additionally, expanding applications in hydroponics and foliar sprays in horticulture bolster its adoption, positioning this segment for robust expansion.
During the forecast period, the North America region is expected to hold the largest market share due to stringent animal nutrition regulations, advanced agricultural practices, and high consumer awareness of dietary supplements. The region's well-established livestock industry and emphasis on meat quality drive demand for selenium-enriched feed. Moreover, strong R&D capabilities and the presence of key players like Archer Daniels Midland and Cargill enhance market dominance. Government initiatives promoting micronutrient fortification in food and feed further solidify North America's leading position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to expanding livestock production, rising meat consumption, and increasing health consciousness. Countries like China and India are investing in modern farming techniques and nutritional supplements to address selenium deficiencies. Government policies supporting agricultural productivity and urbanization-driven demand for processed foods further accelerate adoption. Additionally, low production costs and untapped potential in emerging economies position the region as a high-growth market, attracting global investments in chelated selenium applications.
Key players in the market
Some of the key players in Chelated Selenium Market include BASF SE, DSM-Firmenich, Cargill, Incorporated, Archer Daniels Midland Company (ADM), Alltech, Zinpro Corporation, Novus International, Inc., Kemin Industries, Inc., Nutreco, Phibro Animal Health Corporation, Lallemand Animal Nutrition, DLG Group, Vitatrace Nutrition, Balchem Corporation, Orffa International B.V., Biochem (EW Group), Virbac SA and Mercer Milling Company.
In September 2024, HarvestPlus and Cargill are excited to announce the NutriHarvest project, a transformative 36-month initiative. This $3 million multi-year project, supported by Cargill and executed by HarvestPlus, is dedicated to increasing access to nutritious food while impacting more than 119,000 farmers across India, Kenya, Tanzania, and Guatemala, and delivering over 17 million nutritious meals.
In August 2024, Fonterra is set to expand its Studholme site in the South Island to create a hub for high value proteins. Fonterra's proteins have enhanced functionality and are designed to perform well in premium product applications such as medical and high-protein sports nutrition. Fonterra CEO Miles Hurrell says the investment of around $75 million is part of the Co-op's strategy to grow value through its world-leading Ingredients business by partnering with customers who value Fonterra's unique offering.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.